Emergence of an effective adaptive cell mediated immune response to Mycobacterium leprae is not impaired in reactive oxygen intermediate-deficient mice

FEMS Immunology and Medical Microbiology

Volumn 51, Issue 1, 2007, Pages 92-101

  Hagge, Deanna A ^a   Marks, Vilma T ^a   Ray, Nashone A ^a   Dietrich, Marilyn A ^b   Kearney, Michael T ^b   Scollard, David M ^a   Krahenbuhl, James L ^a   Adams, Linda B ^a,b  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Granuloma; Knockout mice; Mycobacterium leprae; Phagocyte oxidase; ROI

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; CYTOKINE; HERMES ANTIGEN; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; EFFECTOR CELL; GRANULOMA; IMMUNE RESPONSE; LEPROSY; LYMPHOCYTIC INFILTRATION; MOUSE; MYCOBACTERIUM LEPRAE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CYTOKINES; IMMUNITY, CELLULAR; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM LEPRAE; NADPH OXIDASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 34548549377     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00282.x     Document Type: Article

References (60)

1. Adams LB, Franzblau SG, Vavrin Z, Hibbs JB Jr. Krahenbuhl JL (1991) l-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J Immunol 147 : 1642 1646.
2. Adams LB, Dinauer MC, Morgenstern DE Krahenbuhl JL (1997) Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber Lung Dis 78 : 237 246.
3. Adams LB, Job CK Krahenbuhl JL (2000) Role of inducible nitric oxide synthase in resistance to Mycobacterium leprae in mice. Infect Immun 68 : 5462 5465.
4. Adams LB, Scollard DM, Ray NA, Cooper AM, Frank AA, Orme IM Krahenbuhl JL (2002) The study of mycobacterium leprae infection in interferon-gamma gene - disrupted mice as a model to explore the immunopathologic spectrum of leprosy. J Infect Dis 185 (suppl 1), S1 S8.
5. Bermudez LE (1993) Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide. Clin Exp Immunol 91 : 277 281.
6. Bogdan C, Rollinghoff M Diefenbach A (2000) Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 12 : 64 76.
7. Brozna JP, Horan M, Rademacher JM, Pabst KM Pabst MJ (1991) Monocyte responses to sulfatide from Mycobacterium tuberculosis: inhibition of priming for enhanced release of superoxide, associated with increased secretion of interleukin-1 and tumor necrosis factor alpha, and altered protein phosphorylation. Infect Immun 59 : 2542 2548.
8. Chan J, Fujiwara T, Brennan P, McNeil M, Turco SJ, Sibille JC, Snapper M, Aisen P Bloom BR (1989) Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci USA 86 : 2453 2457.
9. Chan J, Fan XD, Hunter SW, Brennan PJ Bloom BR (1991) Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun 59 : 1755 1761.
10. Chan J, Tanaka K, Carroll D, Flynn J Bloom BR (1995) Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 63 : 736 740.
11. Chehl S, Ruby J, Job CK Hastings RC (1983) The growth of mycobacterium leprae in nude mice. Lepr Rev 54 : 283 304.
12. Co DO, Hogan LH, Il-Kim S Sandor M (2004) T cell contributions to the different phases of granuloma formation. Immunol Lett 92 : 135 142.
13. Cole ST, Eiglmeier K, Parkhill J et al 2001) Massive gene decay in the leprosy bacillus. Nature 409 : 1007 1011.
14. Colston MJ Hilson GR (1976) Growth of Mycobacterium leprae and M. marinum in congenitally athymic (nude) mice. Nature 262 : 399 401.
15. -/-) mice. Infect Immun 68 : 1231 1234.
16. Cooper AM, Adams LB, Dalton DK, Appelberg R Ehlers S (2002) IFN-gamma and NO in mycobacterial disease: new jobs for old hands. Trends Microbiol 10 : 221 226.
17. Doi T, Ando M, Akaike T, Suga M, Sato K Maeda H (1993) Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis. Infect Immun 61 : 1980 1989.
18. Ehlers S, Kutsch S, Benini J, Cooper A, Hahn C, Gerdes J, Orme I, Martin C Rietschel ET (1999) NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads. Immunology 98 : 313 323.
19. El-Benna J, Dang PM, Gougerot-Pocidalo MA Elbim C (2005) Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses. Arch Immunol Ther Exp (Warsz) 53 : 199 206.
20. Flynn JL, Scanga CA, Tanaka KE Chan J (1998) Effects of aminoguanidine on latent murine tuberculosis. J Immunol 160 : 1796 1803.
21. Gomes MS, Florido M, Pais TF Appelberg R (1999) Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J Immunol 162 : 6734 6739.
22. Hagge DA, Ray NA, Krahenbuhl JL Adams LB (2004) An in vitro model for the lepromatous leprosy granuloma: fate of Mycobacterium leprae from target macrophages after interaction with normal and activated effector macrophages. J Immunol 172 : 7771 7779.
23. Holzer TJ, Nelson KE, Schauf V, Crispen RG Andersen BR (1986) Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation. Infect Immun 51 : 514 520.
24. Jackett PS, Aber VR Lowrie DB (1978) Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis. J Gen Microbiol 104 : 37 45.
25. Jackson SH, Gallin JI Holland SM (1995) The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med 182 : 751 758.
26. Jung YJ, LaCourse R, Ryan L North RJ (2002) Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide synthase 2-independent defense in mice. J Exp Med 196 : 991 998.
27. Krahenbuhl J Adams LB (2000) Exploitation of gene knockout mice models to study the pathogenesis of leprosy. Lepr Rev 71 (suppl), S170 S175.
28. Lahiri R, Randhawa B Krahenbuhl J (2005) Application of a viability-staining method for Mycobacterium leprae derived from the athymic (nu/nu) mouse foot pad. J Med Microbiol 54 : 235 242.
29. Launois P, Maillere B, Dieye A, Sarthou JL Bach MA (1989) Human phagocyte oxidative burst activation by BCG, M. leprae, and atypical mycobacteria: defective activation by M. leprae is not reversed by interferon gamma. Cell Immunol 124 : 168 174.
30. Levy L (1975) Superinfection in mice previously infected with Mycobacterium leprae. Infect Immun 11 : 1094 1099.
31. Levy L Ji B (2006) The mouse foot-pad technique for cultivation of Mycobacterium leprae. Lepr Rev 77 : 5 24.
32. Lygren ST, Closs O, Bercouvier H Wayne LG (1986) Catalases, peroxidases, and superoxide dismutases in Mycobacterium leprae and other mycobacteria studied by crossed immunoelectrophoresis and polyacrylamide gel electrophoresis. Infect Immun 54 : 666 672.
33. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK Nathan CF (1997) Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 94 : 5243 5248.
34. Manca C, Paul S, Barry CE III., Freedman VH Kaplan G (1999) Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun 67 : 74 79.
35. Middlebrook G (1954) Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report. Am Rev Tuberc 69 : 471 472.
36. Morgenstern DE, Gifford MA, Li LL, Doerschuk CM Dinauer MC (1997) Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med 185 : 207 218.
37. Moura AC, Modolell M Mariano M (1997) Down-regulatory effect of Mycobacterium leprae cell wall lipids on phagocytosis, oxidative respiratory burst and tumour cell killing by mouse bone marrow derived macrophages. Scand J Immunol 46 : 500 505.
38. Neill MA Klebanoff SJ (1988) The effect of phenolic glycolipid-1 from Mycobacterium leprae on the antimicrobial activity of human macrophages. J Exp Med 167 : 30 42.
39. Ng VH, Cox JS, Sousa AO, MacMicking JD McKinney JD (2004) Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol Microbiol 52 : 1291 1302.
40. Piddington DL, Fang FC, Laessig T, Cooper AM, Orme IM Buchmeier NA (2001) Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst. Infect Immun 69 : 4980 4987.
41. Pollock JD, Williams DA, Gifford MA, Li LL, Du X, Fisherman J, Orkin SH, Doerschuk CM Dinauer MC (1995) Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 9 : 202 209.
42. Rees RJ Weddell AG (1968) Biology of the mycobacterioses. Experimental models for studying leprosy. Ann NY Acad Sci 154 : 214 236.
43. Schlesinger LS Horwitz MA (1991) Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium. J Immunol 147 : 1983 1994.
44. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW Williams DL (2006) The continuing challenges of leprosy. Clin Microbiol Rev 19 : 338 381.
45. -/-) mouse model of chronic granulomatous disease has normal granuloma formation and cytokine responses to Mycobacterium avium and Schistosoma mansoni eggs. Infect Immun 67 : 1659 1665.
46. Sharp AK, Colston MJ Banerjee DK (1985) Susceptibility of Mycobacterium leprae to the bactericidal activity of mouse peritoneal macrophages and to hydrogen peroxide. J Med Microbiol 19 : 77 84.
47. Shepard CC (1960) The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice. J Exp Med 112 : 445 454.
48. Shepard CC McRae DH (1968) A method for counting acid-fast bacteria. Int J Lepr Other Mycobact Dis 36 : 78 82.
49. Sibley LD Krahenbuhl JL (1988a) Defective activation of granuloma macrophages from Mycobacterium leprae-infected nude mice. J Leukoc Biol 43 : 60 66.
50. Sibley LD Krahenbuhl JL (1988b) Induction of unresponsiveness to gamma interferon in macrophages infected with Mycobacterium leprae. Infect Immun 56 : 1912 1919.
51. Thangaraj HS, Lamb FI, Davis EO, Jenner PJ, Jeyakumar LH Colston MJ (1990) Identification, sequencing, and expression of Mycobacterium leprae superoxide dismutase, a major antigen. Infect Immun 58 : 1937 1942.
52. Tomioka H, Sato K, Sano C, Akaki T, Shimizu T, Kajitani H Saito H (1997) Effector molecules of the host defence mechanism against Mycobacterium avium complex: the evidence showing that reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids each alone are not decisive in expression of macrophage antimicrobial activity against the parasites. Clin Exp Immunol 109 : 248 254.
53. Truman RW Krahenbuhl JL (2001) Viable M. leprae as a research reagent. Int J Lepr Other Mycobact Dis 69 : 1 12.
54. Vachula M, Holzer TJ Andersen BR (1989) Suppression of monocyte oxidative response by phenolic glycolipid I of Mycobacterium leprae. J Immunol 142 : 1696 1701.
55. 2 production: reversal by gamma interferon. Infect Immun 57 : 864 869.
56. Welch TM, Gelber RH, Murray LP, Ng H, O'Neill SM Levy L (1980) Viability of Mycobacterium leprae after multiplication in mice. Infect Immun 30 : 325 328.
57. Wheeler PR Gregory D (1980) Superoxide dismutase, peroxidatic activity and catalase in Mycobacterium leprae purified from armadillo liver. J Gen Microbiol 121 : 457 464.
58. Williams DL, Torrero M, Wheeler PR, Truman RW, Yoder M, Morrison N, Bishai WR Gillis TP (2004) Biological implications of Mycobacterium leprae gene expression during infection. J Mol Microbiol Biotechnol 8 : 58 72.
59. Yuan Y, Lee RE, Besra GS, Belisle JT Barry CE III. (1995) Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 92 : 6630 6634.
60. Zahrt TC Deretic V (2002) Reactive nitrogen and oxygen intermediates and bacterial defenses: unusual adaptations in Mycobacterium tuberculosis. Antioxid Redox Signal 4 : 141 159.